Metaplastic Breast Cancer

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2026-04-03
Clinical Trial Update: Alpelisib/iNOS Inhibitor/Nab-paclitaxel in Patients With HER2 Negative Metaplastic Breast Cancer (MpBC) [Phase 2]
A Phase 2 trial evaluating a combination of alpelisib, an iNOS inhibitor, and nab-paclitaxel in HER2-negative metaplastic breast cancer, wit…